Clinical trial
High-dose Inhaled NO Therapy for the Prevention of Nosocomial Pneumonia After Cardiac Surgery With Cardiopulmonary Bypass
NCT06162455 is registered in ClinicalTrials.gov with Tomsk National Research Medical Center of the Russian Academy of Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- High-dose Inhaled NO Therapy for the Prevention of Nosocomial Pneumonia After Cardiac Surgery With Cardiopulmonary Bypass
- Lead sponsor
- Tomsk National Research Medical Center of the Russian Academy of Sciences
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 17, 2023
- Completion date
- February 6, 2024
- Enrollment
- 74 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nosocomial pneumonia